Rapid Micro Biosystems Inc reports results for the quarter ended March 31 - Earnings Summary

Rapid Micro Biosystems

09/05/2025 14:32

Rapid Micro Biosystems Inc RPID.OQ reported a quarterly adjusted loss of 26 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -31 cents.  The mean expectation of three analysts for the quarter was for a loss of 27 cents per share.

Revenue rose 28.4% to $7.21 million from a year ago; analysts expected $6.60 million.

Rapid Micro Biosystems Inc's reported EPS for the quarter was a loss of 26 cents​.

The company reported a quarterly loss of $11.26 million.

Rapid Micro Biosystems Inc shares had fallen by 7.2% this quarter and gained 172.2% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 28.6% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Rapid Micro Biosystems Inc is $8.00

This summary was machine generated from LSEG data May 9 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.27
-0.26
Beat
Dec. 31 2024
-0.23
-0.22
Beat
Sep. 30 2024
-0.25
-0.26
Missed
Jun. 30 2024
-0.28
-0.29
Missed